Franch: Substance Basis, Mechanism of Action and Quality Control Standard Revealed Based on the Q-marker Concept and New Strategy of Systemic Pharmacology and Biosynthesis Research

Overview

Journal Curr Top Med Chem

Publisher Bentham Science Publishers

Specialty Chemistry

Date 2024 Aug 13

PMID 39136504

Authors

Yating Zheng

Mengyu Zhang

Xiaoqing Wu

Rui Tan

Hezhong Jiang

Affiliations

Soon will be listed here.

Abstract

Franch. (Ranunculaceae, Coptis), a traditional Chinese medicine (TCM) with thousands of years of clinical use history, also a natural medicine available in many countries, has wide pharmacological mechanisms and significant bioactivity according to its traditional efficacy combined with modern scientific research. The quality marker (Q-marker) of Franch. is predicted in this paper based on the chemical composition and pharmacological effects of the plant, as well as the current system pharmacology, plant relatedness, biosynthetic pathways and quantitative analysis of multi-components (QAMS). Natural medicine has the advantage of being multi-component, multi-pathway and multi-target. However, there are few reports on safety evaluation. This review predicts the Q-marker of , the safety and efficacy of is provided. Studies from 1975 to 2023 were reviewed from PubMed, Elsevier, ScienceDirect, Web of Science, SpringerLink, and Google Scholar. Alkaloids and organic acids are the two main component categories of Q-Markers. The specific alkaloids identified through predictive results include berberine, coptisine, palmatine, epiberberine, jatrorrhizine, columbamine, and berberrubine. Quinic acid and malic acid, due to their influence on the content of alkaloids and their ability to aid in identifying the active components of , are also considered Q-markers. The research strategy of "exploring chemical components, exploring pharmacological activities, constructing pharmacological mechanism network and locating biosynthetic pathways" was used to accurately screen the quality markers of in this review and summarise the quality evaluation methods and criteria. In addition, we updated the biosynthetic pathway of and refined the specific synthetic pathways of jatrorrhizine (quality markers) and epiberberine (quality markers). Finally, we summarised the quality evaluation methods of , which provide an important reference for resource evaluation and provide a key reference for the discovery of new functional chemical entities for natural medicines.

References

Chang N . In vitro antibacterial action of extracts from coptis root. Proc Soc Exp Biol Med. 1948; 69(1):141-3. DOI: 10.3181/00379727-69-16644p. View

Chen Y, Gao Q, Zou T, Wang B, Liu S, Sheng J . Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study. Lancet Gastroenterol Hepatol. 2020; 5(3):267-275. DOI: 10.1016/S2468-1253(19)30409-1. View

Liu Q, Liu S, Gao L, Sun S, Huan Y, Li C . Anti-diabetic effects and mechanisms of action of a Chinese herbal medicine preparation JQ-R and in diabetic KK mice. Acta Pharm Sin B. 2017; 7(4):461-469. PMC: 5518656. DOI: 10.1016/j.apsb.2017.04.010. View

Gao L, Liu Q, Liu S, Chen Z, Li C, Lei L . A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice. J Ethnopharmacol. 2013; 151(1):675-85. DOI: 10.1016/j.jep.2013.11.024. View

Cui L, Liu M, Chang X, Sun K . The inhibiting effect of the Coptis chinensis polysaccharide on the type II diabetic mice. Biomed Pharmacother. 2016; 81:111-119. DOI: 10.1016/j.biopha.2016.03.038. View

Li Y, Wang B, Liu C, Zhu X, Zhang P, Yu H . Inhibiting c-Jun N-terminal kinase (JNK)-mediated apoptotic signaling pathway in PC12 cells by a polysaccharide (CCP) from Coptis chinensis against Amyloid-β (Aβ)-induced neurotoxicity. Int J Biol Macromol. 2019; 134:565-574. DOI: 10.1016/j.ijbiomac.2019.05.041. View

Chen Q, Ren R, Zhang Q, Wu J, Zhang Y, Xue M . Coptis chinensis Franch polysaccharides provide a dynamically regulation on intestinal microenvironment, based on the intestinal flora and mucosal immunity. J Ethnopharmacol. 2020; 267:113542. DOI: 10.1016/j.jep.2020.113542. View

Wang J, Wang L, Lou G, Zeng H, Hu J, Huang Q . Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. Pharm Biol. 2019; 57(1):193-225. PMC: 6461078. DOI: 10.1080/13880209.2019.1577466. View

Chen H, Ye X, Cui X, He K, Jin Y, Chen Z . Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells. Fitoterapia. 2011; 83(1):67-73. DOI: 10.1016/j.fitote.2011.09.014. View

10.

Jung H, Yoon N, Bae H, Min B, Choi J . Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase. Arch Pharm Res. 2008; 31(11):1405-12. DOI: 10.1007/s12272-001-2124-z. View

11.

Xu H . [Studies on alkaloids of Asteropyrum cavaleriei (Lévl. et Vant.) Drumm. et Hutch]. Zhongguo Zhong Yao Za Zhi. 2003; 25(8):486-8. View

12.

Li Z, Wang Q, Feng Y, Luo X, Fan M, Yang S . [Chemical constituents from Coptis chinensis]. Zhong Yao Cai. 2013; 35(9):1438-41. View

13.

Tian P, Zhang X, Wang H, Li P, Liu Y, Li S . Rapid Analysis of Components in Franch by Ultra-Performance Liquid Chromatography with Quadrupole Time-of-Flight Mass Spectrometry. Pharmacogn Mag. 2017; 13(49):175-179. PMC: 5307904. DOI: 10.4103/0973-1296.197635. View

14.

Yang T, Chao H, Shi L, Chang T, Lin H, Chang W . Alkaloids from Coptis chinensis root promote glucose uptake in C2C12 myotubes. Fitoterapia. 2014; 93:239-44. DOI: 10.1016/j.fitote.2014.01.008. View

15.

Min Y, Yang M, Lee K, Kim K, Choi S, Lee K . Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome of Coptis japonica Makino. Arch Pharm Res. 2006; 29(9):757-61. DOI: 10.1007/BF02974076. View

16.

Noguchi M, Kubo M, Hayashi T, Ono M . Studies on the pharmaceutical quality evaluation of crude drug preparations used in orient medicine "Kampoo". III. Precipitation reaction of glycyrrhizin with alkaloids or alkaloidal crude drugs in aqueous solution. Chem Pharm Bull (Tokyo). 1978; 26(12):3652-7. DOI: 10.1248/cpb.26.3652. View

17.

Chen L, Wang L, Zhang Q, Zhang S, Ye W . [Non-alkaloid chemical constituents from Coptis chinensis]. Zhongguo Zhong Yao Za Zhi. 2012; 37(9):1241-4. View

18.

Habtemariam S . Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacol Res. 2020; 155:104722. DOI: 10.1016/j.phrs.2020.104722. View

19.

Wei W, Zeng Q, Wang Y, Guo X, Fan T, Li Y . Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. Acta Pharm Sin B. 2023; 13(5):2138-2151. PMC: 10213791. DOI: 10.1016/j.apsb.2022.12.009. View

20.

Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G . Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics. 2019; 9(7):1923-1951. PMC: 6485276. DOI: 10.7150/thno.30787. View